Charity buys Merck vaccine to thwart Ebola comeback
Charity alliance Gavi committed to buy $5 million (4.6 million euros) worth of an experimental Ebola vaccine on Wednesday from US drugmaker Merck, enough it hopes to thwart any return of the epidemic that killed thousands.
Jan 20, 2016
0
5